• +33 (0)3 74 00 81 00

  • philippe.froguel@cnrs.fr

  • PreciDIAB, Pôle Recherche,
    1 place de Verdun 59045 Lille Cedex - France

Fighting Diabetes and its complications

PreciDIAB allows the most productive basic researchers in diabetes in France to work with physicians, and the private sector to develop world-class translational projects with clinical implications, taking advantage of their fundamental expertise and state of art platforms.

They can run competitive holistic analyses

Based on its holistic basic research outcomes, and strengthened by a first class diabetes Clinical Trial Unit (PreciDIAB –CTU), PreciDIAB will develop clinical studies towards a new paradigm in diabetes prevention and management centered on each patient’s characteristics and taking advantage of a range of innovations customized for every patient facing any situation.

PreciDIAB ambitions are

©Eurasanté Copyright 2017. All rights reserved.